One of the Largest Healthcare Providers in North India, Bihar and Jharkhand with a First Mover Advantage and a Well-Recognized Brand.
Strong Focus on Tertiary and Quaternary Care with High Contribution from CONGOR Specialties.
Capital-Efficient and Flexible Operating Model with Disciplined Expansion.
Delivering High-Quality Clinical Care Through Renowned Clinicians, Supported with Modern Equipment.
Digital Technology Enabling Clinical Effectiveness, Patient Experience and Operational Efficiencies.
Doctor-Led Professional Management Team with Proven Execution Capabilities.
The Company has incurred losses during Fiscals 2025 and 2024 of Rs. (579.83) million and Rs. (153.31) million, respectively, on a consolidated basis. While the company were profitable in Fiscal 2026, its cannot assure you that the company will continue to remain profitable in the future.
The company's Subsidiaries, Paras Healthcare (Ranchi) Private Limited and Plus Medicare Hospitals Private Limited have collectively incurred a loss of Rs. (520.89) million, Rs. (822.38) million and Rs. (872.69) million during Fiscals 2026, 2025 and 2024, respectively. Its cannot assure you that these Subsidiaries will turn profitable in the future.
The company is highly dependent on doctors, nurses, other healthcare professionals and housekeeping and support staff for its operations. The company has experienced high attrition rates of 60.38%, 66.74% and 65.27% in Fiscals 2026, 2025 and 2024, respectively. If the company is unable to reduce or manage the attrition rates of these professionals, its business, results of operations and financial condition may be adversely affected.
Five of the company eight hospitals are located in North India. In Fiscals 2026, 2025 and 2024, the revenue from these hospitals accounted for 66.07%, 68.40% and 67.33% of its revenue from operations, respectively. Any adverse developments affecting these hospitals or the regions in which they are located could affect the company business, results of operations and financial condition.
The company generates a significant portion of its revenue from the provision of cardiac sciences, oncology sciences, neuro sciences, gastro sciences, orthopedics and sports injury and renal sciences (collectively, "CONGOR") specialties, which contributed 74.70%, 71.92% and 72.34% of the company revenue from operations in Fiscals 2026, 2025 and 2024, respectively. Any adverse developments in the demand for such services could adversely affect its business, results of operations and financial condition.
The provision of healthcare services involves high costs such as employee benefit expenses, retainers and consultants fee and purchases of stock-in-trade, which together accounted for 65.08%, 63.69% and 66.95% of the company total expenses in Fiscals 2026, 2025 and 2024, respectively. If the company fail to pass on these costs to patients, its business, results of operations and financial condition could be adversely affected.
The company conduct the operations of six of its eight hospitals on leased premises. The company operates five hospitals through revenue share arrangements and long-term leases, and its operates one hospital pursuant to a public-private partnership arrangement. Any adverse developments in the company relationships with its lessors or counterparties, or the company inability to renew such arrangements, could adversely affect its business, financial condition and results of operations.
There are outstanding litigations against the Company, Subsidiaries, Promoter, Directors, Key Managerial Personnel and Senior Management, and there were certain regulatory and statutory proceedings initiated against its Promoter and Directors in the past. Any adverse decision in such proceedings, or similar instances in the future may render the company or them liable for penalties, and may adversely affect its business, cash flows and reputation.
The company's empanelments with government health schemes have been subject to adverse actions in the past, including suspension and temporary restrictions, and its may experience such instances in the future, which may adversely affect the company business and results of operations.
The company has experienced delays in construction or commencement of operations at its hospitals in the past (for example, the company Srinagar Hospital, Kanpur Hospital and Ranchi Hospital), and its not be successful in expanding the company hospital network, developing its proposed hospitals or achieving the operating capacities that the company anticipate in a timely manner or at all, which could adversely affect its business, results of operations, financial condition and prospects.
